Martin Espinosa-Bravo

Head of Breast Surgical Unit

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Cancer Biology Cancer Biology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Martin Espinosa-Bravo is the Head of the Breast Surgical Unit at Hospital Universitari Vall d’Hebron, Vall d’Hebron Barcelona Hospital Campus, affiliated with Universitat Autònoma de Barcelona. His research primarily focuses on breast cancer, including risk estimation, treatment outcomes, and patient quality of life. Recent articles authored by him explore topics such as the activity of HER3-directed therapies, health-related quality of life post-surgery, and prognostic factors in early breast cancer. He is based in Spain, country code 34.

Articles (10)

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (5)

Amanda Caroline Dawson

Clinical Dean

University of Newcastle

AUSTRALIA

View details

Stefania Angela Piccioni

Università degli Studi di Siena

ITALY

View details

Merrill McHoney

University of Edinburgh

UNITED KINGDOM

View details

Sumir Gandhi

Associate Professor

New York University College of Dentistry

UNITED STATES

View details

Ahmad Ghazal

CZECH REPUBLIC

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Martin Espinosa-Bravo

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study

Activity of patritumab deruxtecan, a HER3-directed antibody drug conjugate, in early breast cancer according to ERBB3 expression: Interim analysis results of a window-of-opportunity study (SOLTI-1805 TOT-HER3)

Breast cancer risk estimation (CanRisk tool) and perception in unaffected women with family history of breast cancer

EPClin vs OncotypeDx in invasive lobular cancer (ILC)

Health-Related Quality of Life After Nipple-Sparing Mastectomy: Results From the INSPIRE Registry

Long-term prediction of clinical outcomes by the 21-gene test in HR+HER2-breast cancer patients with residual disease after neoadjuvant chemotherapy

Patritumab deruxtecan (HER3-DXd) in early-stage HR+/HER2-breast cancer: Final results of the SOLTI TOT-HER3 window of opportunity trial

Prognostic value of ctDNA detection in patients with early breast cancer undergoing neoadjuvant therapy: A systematic review and meta-analysis

Safety of conservative surgery with accelerated partial breast re-irradiation for isolated ipsilateral breast cancer recurrence regardless of immunohistochemical subtype. A multicentric prospective study

Dietary changes and food habits: social and clinical determinants in a cohort of women diagnosed with breast cancer in Barcelona (DAMA cohort)

Collaborators (5)

Amanda Caroline Dawson

Stefania Angela Piccioni

Merrill McHoney

Sumir Gandhi

Ahmad Ghazal

Make your next move.